- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07485608
Reducing Lead Dust Exposure in Older Housing
March 17, 2026 updated by: Masako Morishita, Michigan State University
Reducing Lead Dust Exposure and Childhood Blood Lead Levels in Older Housing in Michigan
The objective of this study is to assess the effectiveness of portable air filtration (PAF) for mitigating lead dust exposures and reducing childhood blood lead levels in older housing.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
In close collaboration with local health departments, this project will enroll 40 participants who (1) reside in housing built before 1970, and (2) have children under six years of age with blood lead levels (BLL) >5 μg/dL.
Specific objectives include (1) assess reduction of Pb dust exposure via the intervention, (2) assess the ability of PAF to reduce childhood BLL indirectly via reductions in Pb dust exposure, and (3) develop evidence-based exposure reduction guidance for wider public use of PAF.
The project team will measure Pb levels in (1) suspended dust, (2) floor dust, and (3) children's blood before the start and finish of the two-month-long intervention as well as at the midpoint.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tuan Nguyen, BS
- Phone Number: 517-884-2043
- Email: nguye620@msu.edu
Study Contact Backup
- Name: Masako Morishita, PhD
- Phone Number: 517-884-0463
- Email: tomoko@msu.edu
Study Locations
-
-
Michigan
-
East Lansing, Michigan, United States, 48824
- Recruiting
- Michigan State University
-
Contact:
- Tuan Nguyen, BS
- Phone Number: 517-884-2043
- Email: nguye620@msu.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- child under seven years of age with BLL >5 µg/dL,
- child must reside in housing built before 1978, and
- child must sleep at home during participation in the two month-long study.
Exclusion Criteria:
- anything in child's health history that could affect the study results, or
- any circumstance that could interfere with guardian's/parent's ability to consent and/or participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: air filtration systems
Portable air filtration units will be kept running in homes for two months.
|
Two portable air filtration units placed in subjects' homes (one in child's bedroom and one in living room) will be kept running for two months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in blood lead level
Time Frame: After two months at the end of the intervention
|
change in blood lead level (in ug/dL).
|
After two months at the end of the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2022
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
November 30, 2026
Study Registration Dates
First Submitted
May 2, 2023
First Submitted That Met QC Criteria
March 17, 2026
First Posted (Actual)
March 20, 2026
Study Record Updates
Last Update Posted (Actual)
March 20, 2026
Last Update Submitted That Met QC Criteria
March 17, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- MILTS0025-21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Elevated Blood Lead Levels
-
Novozymes A/SUniversidad Iberoamericana A.C., Mexico; Linus Biotechnology IncCompletedEffect of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Young Women of Child-bearing AgeElevated Blood Lead LevelsMexico
-
Novozymes A/SBeijing Children's Hospital; Chengdu Women's and Children's Central Hospital; Beijing Clinical Service Center and other collaboratorsCompletedElevated Blood Lead LevelsChina
-
Aga Khan UniversityPakistan Science FoundationCompleted
-
University of WashingtonNational Institutes of Health (NIH); National Institute of Environmental Health...Not yet recruiting
-
Zimmer BiometCompletedTissue Reaction | Elevated Blood Ion LevelsUnited States
-
Nonin Medical, IncCompleted
-
Charite University, Berlin, GermanyUnknownElevated Lipoprotein(a) LevelsGermany
-
Nonin Medical, IncUniversity of California, San FranciscoCompleted
-
Unilever R&DCompletedHealthy | Mildly Elevated Cholesterol LevelsSweden
-
KGK Science Inc.Healthy Directions, LLCCompletedCoQ10 Blood Levels | CoQ10 Blood Levels With Statin UseCanada
Clinical Trials on portable air filtration systems
-
Michigan State UniversityUniversity of MichiganCompletedCardiovascular Diseases in Old Age
-
Environmental Protection Agency (EPA)University of North Carolina, Chapel HillActive, not recruitingCardiovascular Diseases | Respiratory Tract DiseasesUnited States
-
The University of Texas at ArlingtonRebuilding Together North TexasRecruitingQuality of Life | Stress | Sleep Quality | Pulmonary Function | Asthma ControlUnited States
-
UConn HealthTufts University; National Institute of Environmental Health Sciences (NIEHS); Somerville Transportation Equity Partnership, Inc... and other collaboratorsCompletedBlood Pressure | Cardiovascular Risk FactorUnited States
-
Fudan UniversityCompletedInflammation | Blood Pressure | Pulmonary Function | CoagulationChina
-
University of WashingtonRecruiting
-
Norwegian Institute of Public HealthSINTEF Health ResearchActive, not recruitingFeasibility | AcceptabilityNorway
-
NYU Langone HealthCompleted
-
University of MichiganNational Institute of Nursing Research (NINR); Michigan State UniversityCompletedCardiometabolic HealthUnited States
-
Tufts UniversityCompleted